Skip to main content
. 2022 Mar 16;12(3):249. doi: 10.3390/metabo12030249

Figure 2.

Figure 2

Counts of drugs taken by 6000 QBB participants, ordered by ATC therapeutic subgroup. Subgroups with over 100 counts are: A10:DRUGS USED IN DIABETES (795), C10:LIPID MODIFYING AGENTS (700), H03:THYROID THERAPY (495), M01:ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS (488), A11:VITAMINS (430), C07:BETA BLOCKING AGENTS (430), C09:AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM (363), B01:ANTITHROMBOTIC AGENTS (350), N02:ANALGESICS (341), A01:STOMATOLOGICAL PREPARATIONS (321), G01:GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS (312), B03:ANTIANEMIC PREPARATIONS (285), A02:DRUGS FOR ACID RELATED DISORDERS (239), M05:DRUGS FOR TREATMENT OF BONE DISEASES (174), S01:OPHTHALMOLOGICALS (132). See Supplementary Table S1 for all subgroup definitions and all counts.